Cargando…

Erratum to: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy

Detalles Bibliográficos
Autores principales:	Li, Heng, Yu, Gan, Shi, Runlin, Lang, Bin, Chen, Xianguo, Xia, Ding, Xiao, Haibing, Guo, Xiaolin, Guan, Wei, Ye, Zhangqun, Xiao, Wei, Xu, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464636/ http://dx.doi.org/10.1186/1476-4598-13-183

Ejemplares similares

Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2014)

Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2022)

Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence
por: Xiao, Wei, et al.
Publicado: (2014)

Erratum: Vol. 66, No. 34
Publicado: (2017)

Erratum: Vol. 66 No. 34
Publicado: (2017)

Erratum: Vol. 69, No. 34
Publicado: (2020)

Erratum to “The impact of intra-fractional bladder filling on ‘‘Plan of the day” adaptive bladder radiotherapy” [Tech. Innov. Patient Supp. Radiat. Oncol. 9 (2019) 31–34]
por: Krishnan, Aisling, et al.
Publicado: (2019)

Erratum to: Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma
por: Tanaka, Yoshihiro, et al.
Publicado: (2016)

Erratum to: Transportan 10 improves the anticancer activity of cisplatin
por: Rusiecka, Izabela, et al.
Publicado: (2016)

A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer
por: Zhou, Hui, et al.
Publicado: (2015)

Long noncoding RNA LINC01123 promotes the proliferation and invasion of hepatocellular carcinoma cells by modulating the miR-34a-5p/TUFT1 axis: Erratum
por: Xiao, Zunqiang, et al.
Publicado: (2021)

Long noncoding RNA LINC01123 promotes the proliferation and invasion of hepatocellular carcinoma cells by modulating the miR-34a-5p/TUFT1 axis: Erratum
por: Xiao, Zunqiang, et al.
Publicado: (2021)

Erratum to: Synthetic and natural antioxidants attenuate cisplatin-induced vomiting
por: Alam, Javaid, et al.
Publicado: (2017)

Erratum to: Brave new epigenomes: the dawn of epigenetic engineering
por: Köferle, Anna, et al.
Publicado: (2015)

Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum
por: Yan, Libin, et al.
Publicado: (2022)

Erratum: Ancestral vinclozolin exposure alters the epigenetic transgenerational inheritance of sperm small noncoding RNAs
por: Schuster, Andrew, et al.
Publicado: (2016)

MicroRNA-10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer
por: Xiao, Haibing, et al.
Publicado: (2022)

Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts: Erratum
por: Xu, Jianbin, et al.
Publicado: (2022)

Erratum to: TOPK Activation Exerts Protective Effects on Cisplatin-induced Acute Kidney Injury
por: Zhang, Hui, et al.
Publicado: (2022)

Erratum to: Expression and function of phosphodiesterases (PDEs) in the rat urinary bladder
por: Zhu, Xiaofei, et al.
Publicado: (2017)

Erratum to “Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy”
por: Perrone, Lorena, et al.
Publicado: (2014)

Erratum to: Conservation of Aging and Cancer Epigenetic Signatures across Human and Mouse
Publicado: (2021)

Erratum to “Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis”
por: Han, Chenglin, et al.
Publicado: (2021)

Erratum to: Transmission risk of patients with COVID-19 meeting discharge criteria should be interpreted with caution
por: Su, Jun-wei, et al.
Publicado: (2020)

Depletion of CDC5L inhibits bladder cancer tumorigenesis: Erratum
por: Zhang, Ziwei, et al.
Publicado: (2022)

Erratum: Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome
por: Kokosar, Milana, et al.
Publicado: (2016)

Erratum to epigenetic hypomethylation and upregulation of GD3s in triple negative breast cancer
Publicado: (2022)

Erratum: Upregulation of miR-9 Target CBX7 Regulates Invasion Ability of Bladder Transitional Cell Carcinoma
por: Xie, Dalong, et al.
Publicado: (2020)

Erratum: Endovascular Repair of Blunt Popliteal Arterial Injuries
por: Zhong, Shan, et al.
Publicado: (2016)

Erratum: Intra-arterial chemotherapy in retinoblastoma – A paradigm change
Publicado: (2019)

Erratum: Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis
por: Qi, Xiaofeng, et al.
Publicado: (2017)

EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human bladder cancer: Erratum
por: Zhou, Qiang, et al.
Publicado: (2022)

Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
por: Kamat, Ashish M., et al.
Publicado: (2017)

ERRATUM: Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberg Tumor
por: Cho, Jang Ho, et al.
Publicado: (2018)

Erratum to: Promoter-like epigenetic signatures in exons displaying cell type-specific splicing
por: Curado, Joao, et al.
Publicado: (2016)

Erratum for Saha, “Histone Modifications and Other Facets of Epigenetic Regulation in Trypanosomatids: Leaving Their Mark”
por: Saha, Swati
Publicado: (2021)

Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis: Erratum
por: Tian, Xiao-Peng, et al.
Publicado: (2021)

Erratum to: Increased miR‐34c mediates synaptic deficits by targeting synaptotagmin 1 through ROS‐JNK‐p53 pathway in Alzheimer's disease
Publicado: (2023)

Erratum to: Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
por: Escobar, Yolanda, et al.
Publicado: (2015)

MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum
por: Yang, Renjie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u9gcgh7ug11bi9vo92h5dtq04t